Moolec Science (MLEC) Total Non-Current Liabilities (2022 - 2026)
Moolec Science (MLEC) reported Total Non-Current Liabilities of $93.1 million for Q1 2026, up 253.61% sequentially from $26.3 million in Q4 2025.
Moolec Science (MLEC) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Moolec Science (MLEC) has 5 years of Total Non-Current Liabilities data on file, last reported at $93.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $93.1 million; the trailing twelve-month figure through Mar 2026 stood at $93.1 million (changed N/A YoY), and the FY2025 full-year result was $53.1 million, down 80.53% from the prior year.
- Total Non-Current Liabilities advanced to $93.1 million in Q1 2026, from $26.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $272.4 million in Q2 2024 to a low of $621000.0 in Q2 2022.
- A 5-year average of $44.1 million and a median of $19.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 8858.23% in 2023 and tumbled 80.53% in 2025, its largest moves.
- Tracing MLEC's Total Non-Current Liabilities over 5 years: stood at $9.6 million in 2022, then plunged by 33.88% to $6.4 million in 2023, then surged by 248.16% to $22.1 million in 2024, then advanced by 18.99% to $26.3 million in 2025, then jumped by 253.61% to $93.1 million in 2026.
- Business Quant data shows MLEC's Total Non-Current Liabilities at $93.1 million in Q1 2026, $26.3 million in Q4 2025, and $53.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.28 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.98 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 949,738.67 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 746.94 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | 93.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.10 Mn |
| Dec 31, 2025 | 26.33 Mn |
| Jun 30, 2025 | 53.05 Mn |
| Dec 31, 2024 | 22.13 Mn |
| Sep 30, 2024 | 19.50 Mn |
| Jun 30, 2024 | 272.43 Mn |
| Mar 31, 2024 | 11.49 Mn |
| Dec 31, 2023 | 6.36 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 55.63 Mn |
| Mar 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 9.61 Mn |
| Jun 30, 2022 | 621,000.00 |